Roman Butler Fullerton & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Roman Butler Fullerton & Co’s Portfolio BMRN Stock Details BMRN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$1.04M	Sell
2022 Q4	$1.64M	Buy
2022 Q3	$1.09M	Buy
2022 Q2	$902K	Buy
2020 Q3	–	Sell
2020 Q2	$936K	Sell
2020 Q1	$708K	Buy